FDA Calendar

June 24-27, Boston

THE ENDOCRINE SOCIETY'S 88th ANNUAL MEETING

Includes presentation from Manhattan Pharmaceuticals Inc. on effect of chronic or intermittent oral administration of Oleoyl-estrone on food intake, body weight and body composition in normal rats; presentation from Insmed Inc. on its insulin-like growth factor drug, Iplex; and presentation from GTx Inc. on preclinical studies describing the bone-promoting activities and possible mechanisms for tissue selectivity with its selective androgen receptor modulators

June 26-27, Philadelphia

2006 TARGETING UBIQUITIN FOR DRUG DISCOVERY AND DEVELOPMENT CONFERENCE

Includes presentation from Rigel Pharmaceuticals Inc. on mechanisms of ubiquitin chain synthesis onto substrates of SCF ubiquitin ligases

June 27-28, London

FIRST IBC EUROPEAN OCULAR ANTI-ANGIOGENESIS CONFERENCE

Includes presentation from Genaera Corp. on its phase 2 clinical trials with Evizon for the treatment of wet age-related muscular degeneration

June 28, Rockville, Md.

PEDIATRIC ETHICS SUBCOMMITTEE OF THE PEDIATRIC ADVISORY COMMITTEE MEETING (FDA)

Committee to discuss a referral by an Institutional Review Board of a proposed clinical investigation that involves both an FDA regulated product and research involving children as subjects that may be supported by HHS titled "Precursor Preference in Surfactant Synthesis of Newborns"

June 28-July 1, Barcelona, Spain

8th WORLD CONGRESS ON GASTROINTESTINAL CANCER

Includes presentation from Adventrx Pharmaceuticals Inc. on the response to CoFactor, a folate-based biomodulator drug designed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-fluorouracil

June 29-30, Rockville, Md.

PEDIATRIC ADVISORY COMMITTEE MEETING (FDA)

Committee to hear and discuss the recommendation of the Pediatric Ethics Subcommittee regarding a referral by an Institution Review Board of a proposed clinical investigation involving children as subjects that is regulated by FDA and is conducted or supported by DHHS; to discuss a report by the agency on Adverse Event Reporting for ethinyl estradiol; norgestimate (Ortho Tri-Cyclen), ciprofloxacin (Cipro), tolterodine (Detrol LA), leflunomide (Arave), paricalcitol (Zemplar), zolmitriptan (Zomig), dorzolamide Trusopt

July 11, Rio Grande, Puerto Rico

ANNUAL MEETING OF THE AMERICAN SOCIETY FOR PHOTOBIOLOGY

Includes presentation from Provectus Pharmaceuticals on its topical drug Xantryl for infections caused by highly dangerous antibiotic resistant bacteria

July 9-13, Chicago

25th BIENNIAL CONGRESS OF THE COLLEGIUM INTERNATIONALE NEURO-PSYCHOPHARMOCOLOGICUM

Includes presentation from DOV Pharmaceutical Inc. on phase 3 trial of bicifadine in patients with chronic low back pain

July 12-15, Washington

13th WORLD CONFERENCE ON TOBACCO OR HEALTH

Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure

July 13-14, Gaithersburg, Md.

PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on the implications of recently available data related to the safety of long-acting beta-agonist bronchodilators and the continued need for the essential use designations of prescription drugs for the treatment of asthma and chronic obstructive pulmonary disease

July 13-15, Greenbelt, Md.

FOOD ADVISORY COMMITTEE MEETING (FDA)

Includes evaluation on the CFSAN Threshold Working Group draft report "Approaches to Establish Thresholds for Major Food Allergens and Gluten" as well as discussion on the draft report's approaches for food allergen thresholds and gluten thresholds

July 15, Gaithersburg, Md.

IMMUNOLOGY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)

Committee to hear presentation on the FDA Critical Path Initiative and a presentation by the Office of Surveillance and Biometrics in the Center for Devices and Radiological Health outlining their responsibility for the review of postmarket study design; to discuss, make recommendations and vote on a premarket approval application for a laboratory assay designed to measure levels of neural thread protein in urine specimens from patients presenting with cognitive complaints or other signs and symptoms of suspected Alzheimer's disease

July 16-20, Madrid, Spain

10th INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE

Includes presentation from Predix Pharmaceuticals on studies with PRX-03140, a proprietary serotonin 4 5-HT4 receptor agonist being developed for Alzheimer's disease; PRX-08066, a proprietary 5-HT2B receptor antagonist being developed for the treatment of pulmonary hypertension and hypertension associated with chronic obstructive pulmonary disease; and PRX-07034, a proprietary 5-HT6 receptor antagonist being developed for the treatment of obesity and also for cognitive impairment

July 23-27, Chicago

AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY ANNUAL MEETING

Includes presentation by PreMD Inc. on abstract for microwell-based format of LungAlert for lung cancer

July 27-28, Tyson's Corner, Va.

2nd ANNUAL OBESITY DRUG DEVELOPMENT SUMMIT

Includes presentation from Manhattan Pharmaceuticals Inc. on oral Oleoyl-estrone for obesity

Sept. 2-6, Barcelona, Spain

WORLD CONGRESS OF CARDIOLOGY 2006

Includes presentation from Vasogen Inc. on phase 3 Acclaim trial of Celacade technology in advanced chronic heart failure

Sept. 3-8, Sydney, Australia

10th INTERNATIONAL CONGRESS ON OBESITY

Includes presentation from Manhattan Pharmaceuticals Inc. on long-term treatment of zucker obese rats with Oleoyl-estrone to decrease expression of pro-inflammation markers in white adipose tissue

Sept. 10-14, Edinburgh, Scotland

INTERNATIONAL CONGRESS OF CLINICAL NEUROPHYSIOLOGY

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid

Sept. 14-17, Copenhagen, Denmark

42nd EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES CONFERENCE

Includes presentation from CeNeS Pharmaceuticals plc on CNS 5161, a neuronal glutamate receptor antagonist

Oct. 14-18, Chicago

AMERICAN SOCIETY FOR ANESTHESIOLOGY MEETING

Includes presentation from CeNeS Pharmaceuticals plc on short-acting sedative CNS 7056X for use in the induction and maintenance of anesthesia

Oct. 18-20, Vienna, Austria

SECOND INTERNATIONAL CONFERENCE ON INFLUENZA VACCINES FOR THE WORLD 2006 MEETING

Includes presentation from Carrington Laboratories Inc. on an inactivated influenza nasal powder vaccine, GelVac

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.